patent/CN-103897043-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103897043-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_078cb8366425c7f7bb46338421d23406
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate	2012-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adcfef94a4386838ceba7489c2eb8424 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080dc20c53158931e7c3ddae5ccb03b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e91259b8a90e5666bfad7400c3316c00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5117e14f03070dc1de424f60c58e1bfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3541f9dd47d051210b6ae1acb13e32c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_310040c67c432fbdd7304a57db770961 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28b3f92b5a1ad2eef799c8bdbf54abc9
publicationDate	2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-103897043-A
titleOfInvention	Preparation and application of a membrane-penetrating polypeptide linked to lapatinib
abstract	The cell-penetrating peptide of the present invention is composed of 24 amino acids, and is an alternate combination of hydrophilicity and hydrophobicity, and contains a large amount of lysine and arginine. The present invention obtains the desired peptide by solid-phase synthesis. The polypeptide is connected with lapatinib by a chemical synthesis method, and the present invention also provides the effect of the linker passing through the blood-brain barrier and the anti-tumor effect.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108707187-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108707187-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105399800-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104774245-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105399800-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112979754-A
priorityDate	2012-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012064429-A2
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465947905 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164073600 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465899304

Total number of triples: 32.